4//SEC Filing
OXIGENE INC 4
Accession 0001181431-14-001349
$OTLCCIK 0000908259operating
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 4:40 PM ET
Size
5.3 KB
Accession
0001181431-14-001349
Insider Transaction Report
Form 4
OXIGENE INCOXGN
CHAPLIN DAVID
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2014-01-02+4,880→ 4,880 totalExercise: $2.79From: 2014-01-02Exp: 2020-01-02→ Common Stock (4,880 underlying)
Footnotes (2)
- [F1]Dr. Chaplin was awarded options to purchase shares of OXiGENE, Inc. common stock, $0.01 par value per share (the "Stock Options"), pursuant to the OXiGENE, Inc. Amended and Restated Non-Employee Director Compensation Policy as partial payment for Board of Director services to be provided through the first six months of 2014.
- [F2]The Stock Options were fully vested as of the grant date.
Documents
Issuer
OXIGENE INC
CIK 0000908259
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000908259
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 4:40 PM ET
- Size
- 5.3 KB